drugset / Trial / NCT06891872
Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine
RandomizedParallel-groupOpen-labelPrevention
Summary
This is a phase Ⅳ clinical trial of live attenuated varicella vaccine manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd.The primary objective of this study is to evaluate the immunogenicity of live attenuated varicella vaccine co-administered with MMR vaccine or DTaP vaccine. The secondary objective is to evaluate the safety of the vaccines when administered simultaneously.
Timeline
- Start
- 2025-05
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DTaP vaccine | Vaccine | — | Intramuscular |
| Subject | MMR vaccine | Vaccine | — | Subcutaneous |
| Subject | Varicella vaccine | Vaccine | — | Subcutaneous |